The Immuno-Oncology Pipeline and the Managed Care Considerations Home Study

 

ACPE UAN #:  0233-0000-17-042-H01-P

Release Date:  July 26, 2017

Expiration Date:  July 26, 2018

Activity Type:  Knowledge-based  

Credit Hours:  1.0 contact hours (0.1 CEU)

Activity Fee:  There is no fee to participate in this home study activity.

Target Audience 

This knowledge-based activity has been designed to meet the educational needs of pharmacists in managed care settings.

Actvity Overview: 

The Immuno-Oncology Pipeline and the Managed Care Considerations 

Cancer has been described in medicine for centuries, so why is there not a cure for it yet? The answer is uncertain, but new research into immunotherapy is showing progress in increasing remission rates of cancer patients. Our immune systems are evolutionarily designed to ward off cancers, but sometimes they do not recognize cancer cells as foreign and/or altered, which is when cancers can grow and metastasize. But what if our immune systems had some help with this detection? This is the aim of immuno-oncology medications.

This program will delve into the different types of immuno-oncology treatments available and how they work, as well as immuno-oncology therapies in the pipeline, and the managed care considerations for these new treatment options.

Learning Objectives 

At the completion of this activity, participants should be able to:

  1. Describe immuno-oncology and the different types of immuno-oncology treatments.
  2. Identify immuno-oncology treatments that are likely to be approved in the next 12 months.
  3. Discuss the mechanism of action, indications, efficacy, and safety of new and emerging immuno-oncology treatments.
  4. Report the likely effect of new immuno-oncology treatments on the managed care market.

Schedule of Educational Activity

  • Pharmacoeconomics of Immuno-oncology - Andrew Hertler, MD, FACP
  • Immuno-oncology Introduction and Pipeline - Edward Li, PharmD, MPH, BCOP

CPE Requirements:   

Participants should claim continuing pharmacy education (CPE) credit for this home study activity only if they have not claimed credit for the live webinar activity on July 26, 2017.  CPE credit will be processed through the AMCP Learn portal and reported directly to CPE Monitor.  Please allow 72 hours for processing and posting in your NABP account.

To receive credit for an online activity you must:

  • Review the full content of the activity.
  • Successfully complete the post-test (required to pass with a score of 70% or higher, it may be taken a maximum of three times).
  • Complete a specific activity evaluation.

System Technical Requirements/Viewing Requirements: System Requirements Courses and learning activities are delivered via your Web browser and Acrobat PDF. For all activities you should have a basic comfort level using a computer and navigating web sites.  View the minimum technical and system requirements for continuing education online learning activities.

As an ACPE-accredited provider, AMCP strictly adheres to the ACPE Standards for Commercial Support and other relevant guidelines and standards to ensure the independence of CPE activities. It is AMCP’s intent that all CPE activities be independent, objective, balanced, evidence-based and free of any commercial bias.

Statement of Commercial Support

This educational activity is supported by an unrestricted education grant from Amgen. 

Moderator:
Christine L. Cooper, PharmD
Education Program Manager
Academy of Managed Care Pharmacy
Alexandria, Virginia

Credit Information

Activity Number Credit Amount Accreditation Period
ACPE UAN #0233-0000-17-042-H01-P 1 Contact Hour July 26, 2017 - July 26, 2018